Recombinant Methionyl Human Leptin Therapy in Replacement Doses Improves Insulin Resistance and Metabolic Profile in Patients with Lipoatrophy and Metabolic Syndrome Induced by the Highly Active Antiretroviral Therapy
Jennifer H. Lee(Beth Israel Deaconess Medical Center), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Epaminondas Sourlas(Boston University), Jean L. Chan(Hadassah Medical Center), Vassilios Raptopoulos(Beth Israel Deaconess Medical Center)
Cited by 162
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k
Obesity and cancer risk: Emerging biological mechanisms and perspectives
|Metabolism|2018|1.6k
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
|Metabolism|2018|1.2k